Polymyositis Clinical Trial
Official title:
Exploration of the Diagnostic Capabilities of Ultrasound of the Oropharynx and Larynx
This study will assess the use of ultrasound-a test that uses sound waves to produce
images-as a diagnostic tool for evaluating speech and swallowing.
The following categories of individuals may be eligible for this study: 1) healthy
volunteers between 20 and 85 years old with normal speech and hearing, 2) patients 6 to 85
years old with developmental neurological deficits in speech or swallowing, and 3) patients
with tumors of the oral cavity, pharynx or larynx being treated at the Greater Baltimore
Medical Center.
Participants will undergo a 30-minute speech and oral motion evaluation, in which they
imitate sounds, words and oral movements while a speech pathologist evaluates their lip,
tongue and palate movements. They may also be asked to drink a small amount of water for
examination of swallowing function.
For the ultrasound examination, a 3/4-inch transducer (device for transmitting and receiving
sound waves) is placed under the participant's chin. While the transducer is in place, the
subject 1) repeats sounds and a series of syllables in several sequences, 2) swallows three
times with and without a small amount of water, and 3) swallows 3 teaspoons of non-fat
pudding. The ultrasound images are recorded on tape for later analysis.
Studies conducted using ultrasound imaging at the NIH, Departments of Rehabilitation Medicine and Diagnostic Radiology, have demonstrated that ultrasound imaging can be used reliably to study speech and swallowing impairments in a variety of conditions and diseases. Since ultrasound is non-invasive with no reported bioeffects, it can be used repeatedly to follow the progression of a disease. Ultrasound imaging of the oral cavity during speech and swallowing allows easy visualization of the tongue/hyoid bone motion and transport of the bolus during swallowing and tongue surface configuration during speech. Images can be obtained in several planes for viewing muscular coordination and timing and specific measures can be obtained from digitized video images. Thus it has widespread clinical research implications for patients with disorders affecting the oral peripheral muscles, salivary gland flow and the central nervous system control of speech and swallowing. While ultrasound technology has been used extensively in Europe to evaluate tumors of the head and neck, its use in this country has been marginal. We plan to compare ultrasound evaluation of tumor staging, tumor volume, and tumor recurrence in patients with tumors of the larynx, oral cavity and hypopharynx. Currently, this is accomplished by CT or MRI scanning procedures. We plan to compare CT/MRI results with ultrasound to determine if this non-invasive technique can be utilized reliably for diagnosis and tracking of oropharyngeal tumors. ;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05833711 -
Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy
|
Phase 2 | |
Completed |
NCT01906372 -
Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
|
Phase 2 | |
Completed |
NCT01813617 -
Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis
|
N/A | |
Completed |
NCT01165008 -
Anakinra in Myositis
|
Phase 2/Phase 3 | |
Recruiting |
NCT05832034 -
Add-on Intravenous Immunoglobulins in Early Myositis
|
Phase 2 | |
Recruiting |
NCT05979441 -
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
|
Phase 3 | |
Not yet recruiting |
NCT05027152 -
Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties
|
N/A | |
Active, not recruiting |
NCT04723303 -
Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)
|
Early Phase 1 | |
Recruiting |
NCT05523167 -
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.
|
Phase 2/Phase 3 | |
Recruiting |
NCT03324152 -
Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis
|
N/A | |
Completed |
NCT02043548 -
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
|
Phase 2 | |
Completed |
NCT03414086 -
Predictor of Clinical Response to Acthar in Myositis
|
||
Completed |
NCT04628936 -
Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.
|
Phase 2 | |
Completed |
NCT00213629 -
myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies
|
N/A | |
Completed |
NCT02971683 -
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
|
Phase 3 | |
Active, not recruiting |
NCT00651040 -
Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With Polymyositis and Dermatomyositis
|
Phase 3 | |
Completed |
NCT00138983 -
Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
|
Phase 3 | |
Completed |
NCT00001331 -
Genetic and Family Studies of Inherited Muscle Diseases
|
N/A | |
Completed |
NCT00001261 -
Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies
|
Phase 2 | |
Completed |
NCT01415219 -
Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis
|
Phase 2 |